Predicting Other Cause Mortality Risk for Older Men with Localized Prostate Cancer: A Dissertation

作者: Daniel M. Frendl

DOI: 10.13028/M2CG6N

关键词:

摘要: Background: Overtreatment of localized prostate cancer (PCa) is a concern as many men die other causes prior to experiencing treatment benefit. This dissertation characterizes the need for assessing cause mortality (OCM) risk in older with PCa and informs efforts identify patients most likely benefit from definitive treatment. Methods: Using linked Surveillance Epidemiology End Results-Medicare Health Outcomes Survey database, 2,931 (mean age=75) newly diagnosed clinical stage T1a-T3a 1998-2009 were identified. Survival analysis methods used compare observed 10-year OCM by primary type. Age health factors predictive type assessed multinomial logistic regression. Predicted estimates Social Security life tables (recommended expectancy evaluation) two estimation tools compared rates. An improved prediction model was developed fitting Fine Gray competing risks models age, sociodemographic, comorbidity, activities daily living, patient-reported data predictors. The tools’ ability discriminate between who died those did not evaluated Harrell’s c-index (range 0.5-1), which also guided new selection. Results: Fifty-four percent underwent radiotherapy while 13% prostatectomy. Twenty-three treated 12% undergoing prostatectomy experienced within 10 years thus considered overtreated. indicative shorter (increased worse physical health, smoking) had little no association assignment but significantly related reductions likelihood overestimated discriminated poorly over (c-index=0.59). Existing less overestimate rates limited discrimination (c-index=0.64). A self-reported Charlson comorbidity index score, overall (excellent-good/fair/poor), smoking, marital status predictors (c-index=0.70). Conclusions: primarily attributable may be reduced pretreatment assessment mortality-related factors. provides prognostic utilizes set five characteristics that better diagnosis than age comorbidity-based assessments alone.

参考文章(71)
James Mohler, Robert R. Bahnson, Barry Boston, J. Erik Busby, Anthony D'Amico, James A. Eastham, Charles A. Enke, Daniel George, Eric Mark Horwitz, Robert P. Huben, Philip Kantoff, Mark Kawachi, Michael Kuettel, Paul H. Lange, Gary MacVicar, Elizabeth R. Plimack, Julio M. Pow-Sang, Mack Roach, Eric Rohren, Bruce J. Roth, Dennis C. Shrieve, Matthew R. Smith, Sandy Srinivas, Przemyslaw Twardowski, Patrick C. Walsh, Prostate cancer. Clinical practice guidelines in oncology. Journal of The National Comprehensive Cancer Network. ,vol. 8, pp. 162- 200 ,(2010) , 10.6004/JNCCN.2010.0012
Steven B. Clauser, Keith M. Bellizzi, Marie Topor, Anita Ambs, Joan L. Warren, Samuel C. "Chris" Haffer, Overview of the SEER—Medicare Health Outcomes Survey Linked Dataset Health Care Financing Review. ,vol. 29, pp. 5- 21 ,(2008)
Timothy J. Daskivich, Julie Lai, Andrew W. Dick, Claude M. Setodji, Janet M. Hanley, Mark S. Litwin, Christopher Saigal, , Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer. Cancer. ,vol. 120, pp. 3642- 3650 ,(2014) , 10.1002/CNCR.28926
Lewis E. Kazis, Avron Spiro, Xinhua S. Ren, Alfredo Selim, Donald R Miller, Samuel C. (Chris) Haffer, Austin Lee, Alaa Hamed, William Rogers, Measurement comparisons of the medical outcomes study and veterans SF-36 health survey. Health Care Financing Review. ,vol. 25, pp. 43- 58 ,(2004)
John A. Taylor, Peter C. Albertsen, Benign and Malignant Diseases of the Prostate Springer, New York, NY. pp. 1069- 1082 ,(2011) , 10.1007/978-1-4419-6999-6_81
Michael Froehner, Rainer Koch, Rainer J. Litz, Oliver W. Hakenberg, Manfred P. Wirth, Which patients are at the highest risk of dying from competing causes ≤10 years after radical prostatectomy? BJUI. ,vol. 110, pp. 206- 210 ,(2012) , 10.1111/J.1464-410X.2011.10693.X
M. Kosinski, Martha S. Bayliss, John E. Ware Jr., William H. Rogers, Anastasia E. Raczek, Colleen A. McHorney, Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study Medical Care. ,vol. 33, ,(1995)
Ayal A. Aizer, Xiangmei Gu, Ming-Hui Chen, Toni K. Choueiri, Neil E. Martin, Jason A. Efstathiou, Andrew S. Hyatt, Powell L. Graham, Quoc-Dien Trinh, Jim C. Hu, Paul L. Nguyen, Cost Implications and Complications of Overtreatment of Low-Risk Prostate Cancer in the United States Journal of The National Comprehensive Cancer Network. ,vol. 13, pp. 61- 68 ,(2015) , 10.6004/JNCCN.2015.0009
ASHUTOSH TEWARI, CHRISTINE COLE JOHNSON, GEORGE DIVINE, E. DAVID CRAWFORD, EDUARD J. GAMITO, RAYMOND DEMERS, MANI MENON, Long-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbidities. The Journal of Urology. ,vol. 171, pp. 1513- 1519 ,(2004) , 10.1097/01.JU.0000117975.40782.95